Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies-Reference-Cited by-同舟云学术

Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies

Published:2022-06-17 Issue:8 Volume:113 Page:2763-2777
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Fukuhara Suguru¹^ORCID,Oshikawa‐Kumade Yuji²³^ORCID,Kogure Yasunori²^ORCID,Shingaki Sumito²^ORCID,Kariyazono Hirokazu²³,Kikukawa Yoshiya²³,Koya Junji²^ORCID,Saito Yuki²⁴^ORCID,Tabata Mariko²⁵^ORCID,Yoshifuji Kota²⁶,Mizuno Kota²⁷,Miyagi‐Maeshima Akiko⁸^ORCID,Matsushita Hiromichi⁹^ORCID,Sugiyama Masanaka¹⁰^ORCID,Ogawa Chitose¹⁰,Inamoto Yoshihiro¹¹^ORCID,Fukuda Takahiro¹¹,Sugano Masato¹²^ORCID,Yamauchi Nobuhiko¹³,Minami Yosuke¹³^ORCID,Hirata Makoto¹⁴^ORCID,Yoshida Teruhiko¹⁴,Kohno Takashi¹⁵^ORCID,Kohsaka Shinji¹⁶^ORCID,Mano Hiroyuki¹⁶^ORCID,Shiraishi Yuichi¹⁷,Ogawa Seishi¹⁸,Izutsu Koji¹^ORCID,Kataoka Keisuke²⁷^ORCID

Affiliation:

1. Department of Hematology National Cancer Center Hospital Tokyo Japan

2. Division of Molecular Oncology National Cancer Center Research Institute Tokyo Japan

3. Diagnostic Division Otsuka Pharmaceutical Co., Ltd. Tokushima Japan

4. Department of Gastroenterology Keio University School of Medicine Tokyo Japan

5. Department of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan

6. Department of Hematology Graduate School of Medicine, Tokyo Medical and Dental University Tokyo Japan

7. Division of Hematology Department of Medicine, Keio University School of Medicine Tokyo Japan

8. Department of Pathology National Cancer Center Hospital Tokyo Japan

9. Department of Laboratory Medicine National Cancer Center Hospital Tokyo Japan

10. Department of Pediatric Oncology National Cancer Center Hospital Tokyo Japan

11. Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan

12. Department of Pathology and Clinical Laboratories National Cancer Center Hospital East Kashiwa Japan

13. Department of Hematology and Oncology National Cancer Center Hospital East Kashiwa Japan

14. Genetic Medicine and Services National Cancer Center Hospital Tokyo Japan

15. Division of Genome Biology National Cancer Center Research Institute Tokyo Japan

16. Division of Cellular Signaling National Cancer Center Research Institute Tokyo Japan

17. Division of Genome Analysis Platform Development National Cancer Center Research Institute Tokyo Japan

18. Department of Pathology and Tumor Biology Graduate School of Medicine, Kyoto University Kyoto Japan

Funder

Otsuka Pharmaceutical

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15427

Reference39 articles.

1. The Cancer Genome Atlas Pan-Cancer analysis project

2. Pan-cancer analysis of whole genomes

3. The Next-Generation Sequencing Revolution and Its Impact on Genomics

4. Next-generation sequencing and empowering personalised cancer medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scenario analysis and multi-criteria decision analysis to explore alternative reimbursement pathways for whole genome sequencing for blood cancer patients;Journal of Cancer Policy;2024-09

2. ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone;Blood;2024-06-06

3. Factors Associated with Inclusion of Japan in Phase I Multiregional Clinical Trials in Oncology;Therapeutic Innovation & Regulatory Science;2024-04-23

4. Comparison of high-throughput single-cell RNA-seq methods for ex vivo drug screening;NAR Genomics and Bioinformatics;2024-01-05

5. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization;Journal of Clinical and Experimental Hematopathology;2024